BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34942655)

  • 1. Thromboinflammation as a Driver of Venous Thromboembolism.
    Gauchel N; Krauel K; Hamad MA; Bode C; Duerschmied D
    Hamostaseologie; 2021 Dec; 41(6):428-432. PubMed ID: 34942655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes.
    Páramo JA
    Reumatol Clin (Engl Ed); 2022 Jan; 18(1):1-4. PubMed ID: 35090606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.
    Loo J; Spittle DA; Newnham M
    Thorax; 2021 Apr; 76(4):412-420. PubMed ID: 33408195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboinflammation in acute injury: infections, heatstroke, and trauma.
    Iba T; Helms J; Levi M; Levy JH
    J Thromb Haemost; 2024 Jan; 22(1):7-22. PubMed ID: 37541590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein, immunothrombosis and venous thromboembolism.
    Dix C; Zeller J; Stevens H; Eisenhardt SU; Shing KSCT; Nero TL; Morton CJ; Parker MW; Peter K; McFadyen JD
    Front Immunol; 2022; 13():1002652. PubMed ID: 36177015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.
    Lim MS; Mcrae S
    Crit Rev Oncol Hematol; 2021 Dec; 168():103529. PubMed ID: 34800652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe COVID-19 disease and thromboinflammation.
    Jerjes-Sánchez C
    Arch Cardiol Mex; 2020; 90(3):257-258. PubMed ID: 32952161
    [No Abstract]   [Full Text] [Related]  

  • 8. The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review.
    Glassman I; Le N; Mirhosseini M; Alcantara CA; Asif A; Goulding A; Muneer S; Singh M; Robison J; Guilford F; Venketaraman V
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):59. PubMed ID: 37005767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunothrombosis and the molecular control of tissue factor by pyroptosis: prospects for new anticoagulants.
    Ryan TAJ; Preston RJS; O'Neill LAJ
    Biochem J; 2022 Mar; 479(6):731-750. PubMed ID: 35344028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases.
    Heestermans M; Poenou G; Duchez AC; Hamzeh-Cognasse H; Bertoletti L; Cognasse F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation.
    Mortazavi-Jahromi SS; Aslani M
    Int Immunopharmacol; 2022 Sep; 110():109040. PubMed ID: 35839566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin Activity Is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness.
    Chen-Goodspeed A; Dronavalli G; Zhang X; Podbielski JM; Patel B; Modis K; Cotton BA; Wade CE; Cardenas JC
    Acta Haematol; 2023; 146(2):117-124. PubMed ID: 36538905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation.
    Zhang Q; Ul Ain Q; Schulz C; Pircher J
    Front Immunol; 2023; 14():1151926. PubMed ID: 37090695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc.
    Sung PS; Sun CP; Tao MH; Hsieh SL
    EMBO Mol Med; 2023 Jul; 15(7):e16351. PubMed ID: 37211986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians.
    Vazquez-Garza E; Jerjes-Sanchez C; Navarrete A; Joya-Harrison J; Rodriguez D
    J Thromb Thrombolysis; 2017 Oct; 44(3):377-385. PubMed ID: 28730407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets.
    Sriram K; Insel PA
    Physiol Rev; 2021 Apr; 101(2):545-567. PubMed ID: 33124941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboinflammation in coronavirus disease 2019: The clot thickens.
    Iffah R; Gavins FNE
    Br J Pharmacol; 2022 May; 179(10):2100-2107. PubMed ID: 34128218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.
    Spyropoulos AC; Weitz JI
    Circulation; 2020 Jul; 142(2):129-132. PubMed ID: 32658609
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of Immunothrombosis by SARS-CoV-2.
    Hernández-Huerta MT; Pérez-Santiago AD; Pérez-Campos Mayoral L; Sánchez Navarro LM; Rodal Canales FJ; Majluf-Cruz A; Matias-Cervantes CA; Pérez-Campos Mayoral E; Romero Díaz C; Mayoral-Andrade G; Martínez Cruz M; Luna Ángel J; Pérez-Campos E
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunothrombosis and thromboinflammation in host defense and disease.
    Martinod K; Deppermann C
    Platelets; 2021 Apr; 32(3):314-324. PubMed ID: 32896192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.